RAMSEY, N.J. (AP) _ Adma Biologics Inc. (ADMA) on Wednesday reported a loss of $18 million in its fourth quarter.
The Ramsey, New Jersey-based company said it had a loss of 39 cents per share.
The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 33 cents per share.
The infectious disease drug developer posted revenue of $4.1 million in the period, which also missed Street forecasts. Four analysts surveyed by Zacks expected $5.2 million.
In the final minutes of trading on Wednesday, the company's shares hit $3.89. A year ago, they were trading at $4.46.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ADMA at https://www.zacks.com/ap/ADMA